<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00936754</url>
  </required_header>
  <id_info>
    <org_study_id>2005-RD-10-CLN2</org_study_id>
    <nct_id>NCT00936754</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human</brief_title>
  <acronym>ICAST</acronym>
  <official_title>Safety and Efficacy of a Unique Dose of a Brown Seaweeds Powder Enriched in Polyphenols on Human</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>innoVactiv Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>innoVactiv Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary endpoint of this trial will be to evaluate the safety of a single administration
      in human of a dose of 500 mg of a polyphenol-rich algal powder when taken 30 minutes before a
      test meal. The secondary endpoint of this trial will be to evaluate if a single
      administration in human of a dose of 500 mg of a polyphenol-rich algal powder is able to
      reduce the rate of carbohydrate absorption as measured by following postprandial glycemia and
      insulinemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of a single 500 mg administration of a brown seaweed extract in human</measure>
    <time_frame>First administration up to 7 days after last administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Significant reduction of glycemic index of test food</measure>
    <time_frame>Immediately after product administration (single use)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant reduction in postprandial glycemia</measure>
    <time_frame>Immediately after product administration (single use)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant reduction in postprandial insulinemia</measure>
    <time_frame>Immediately after product administration (single use)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">23</enrollment>
  <condition>Glycemic Index</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single administration of 500 mg of encapsulated brown seaweed powder, taken 30 minutes before test meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single administration of encapsulated placebo, taken 30 minutes before test meal</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Brown seaweed powder</intervention_name>
    <description>500 mg (in two 250 mg capsules) taken with 250 ml of water 30 minutes before test meal (110g of plain white bread with 250 ml of water)</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Two capsules similar in aspect and weight to active product, taken with 250 ml of water 30 minutes before test meal (110g of plain white bread with 250 ml of water)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteer

          -  BMI between 20 and 30

          -  Non-smoking

        Exclusion Criteria:

          -  Iodine allergy

          -  Diabetes

          -  Use of dietary supplements for duration of study

          -  History of major surgeries or surgeries of the stomach or digestive tract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Couture, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut des nutraceutiques et des aliments fonctionnels</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut des Nutraceutiques et des Aliments Fonctionnels (INAF)</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2009</study_first_submitted>
  <study_first_submitted_qc>July 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2009</study_first_posted>
  <last_update_submitted>January 18, 2010</last_update_submitted>
  <last_update_submitted_qc>January 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jocelyn Bérubé/Scientific Director, Health &amp; Nutrition</name_title>
    <organization>innoVactiv inc.</organization>
  </responsible_party>
  <keyword>Glycemic index</keyword>
  <keyword>Reduction of glycemic index of ingested foods</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

